A common soil fungus (Purpureocillium lilacinum BA1S), when combined with calcium and mild alkalinity, speeds up the ...

The research team established a novel, serum-free and xeno-free, chemically-defined 3D suspension culture system named “3D-default XFSC” to efficiently differentiate human pluripotent stem cells into ...

An international team of scientists has unveiled the most comprehensive model yet that explains how cells control the flow of ...

Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has opened a unique perfusion 'Liver ICU' lab in the Alexandria Centre for Life Sciences.

The new implant, called PRIMA, is the first of its kind capable of restoring reading ability through an eye that had gone ...

In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...

Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has opened a unique perfusion 'Liver ICU' lab in the ...

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

During the COVID-19 pandemic, AI-assisted sequencing pipelines were instrumental in tracking SARS-CoV-2 variants, ...

Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the randomized, double-blind, phase 3 ...